<div>PLEASE GIVE JULIUS’ ACCESS TO A GROUND BREAKING MEDICAL TREATMENT!
</div>
<div><br />
</div>
<div>Julius surprised the medical staﬀ when he survived his birth after suﬀocating for 22 minutes. He is now a young adult living with severe cerebral palsy who continues to endure multiple obstacles. Among them is being grossly underestimated in his intelligence and awareness due to his physical appearance. Julius lives in a body that is outside the fluent connections from his brain, a system of neuro-physiology that most of us take for granted.
</div>
<div><br />
</div>
<div>His mother, Alice, is an artist, a researcher and an educator. She has been Julius’ primary caretaker throughout his life, giving up her own career as a professor in higher education to focus on his welfare. Julius’ little sister is in elementary school and came into the family when Julius was 15-years-old. She is creative in her thinking and talented in dance and song. Already, she has become an advocate for her brother and loves curling up with him in front of a movie.
</div>
<div><br />
</div>
<div>People often mistake Alice as medical staﬀ, due to her in-depth knowledge for Julius’ complicated care. She reminds them, her medical training comes through her loving relationship with her son, not through medical school. Yet, it is not unusual for Alice to correct or guide medical personnel about her son’s care and is often treated as a partner in his treatments by doctors who admire her dedication and non-wavering belief in Julius.
</div>
<div><br />
</div>
<div>This year, Alice’s hope, was lifted when she learned about a breakthrough in tissue engineering technology that could improve Julius’ quality of life. “Is this legit?” she thought. So, she searched further. It’s called CYTOTRON/RFQMR a medical device utilizing Rotational Field Quantum Magnetic Resonance (RFQMR) technology. In simple terms it is a brain magnetic stimulator (similar to an MRI) to promote cell regeneration through fast frequency radio bursts that break down old-dead cells, clearing out scar tissue and allowing room for new cells to grow. Alice’s eyes teared up. The time she invested in research, letter-writing, laboratory visits and seminars gave her an understanding that even with the best advancements of stem cell therapies, scar tissue interferes with cell regeneration. This treatment addresses that very specific problem.
</div>
<div><br />
</div>
<div>Next, she needed to know- Is it safe? Truth be told- YES! The CYTOTRON/RFQMR is in use in the United States for neoplastic disorders of cancer and diabetes. It is also being used to treat Cerebral Palsy and other neuronal disorders, that the technology was intentionally developed for by its inventor Dr. Kumar, Rajah Vija. In the shadow of a double blind study with 22 participants living with cerebral palsy, the treatment is yet to be approved in the USA for C.P. But this does not mean Julius is disqualified from receiving the treatment. NeuroCytonix is a state-of-the Art Treatment Center located in Mexico. The parents of a child who received the treatment in India are responsible for establishing the centre in Mexico. Thanks to their advocacy, NeuroCytonix is only a few hours away via air-travel. The application process requires a medical review and not all candidates are accepted due to their medical baselines. Julius’ relatively stable health and neurophysiology, have given him the baseline required to be an accepted candidate. Julius’ 30-day treatment is scheduled for this summer, with pre and post-opt medical reviews. The family and Julius’ medical specialists here in the U.S. have been working diligently over the past few months to prepare Julius. If you and anyone you know can help oﬀset the costs for this breakthrough in medicine for Julius and his family, please do not hesitate. As Alice ages, it is becoming more diﬃcult for her to lift her son, and yes, she still lifts him every day. The spastic stiﬀness in Julius’ body is taking a toll on both of them. Reducing spasticity is the most common improvement seen in other patients receiving Cytotron Therapy and there are several other benefits that are possible when blockages are removed so that cells can proliferate in the brain, a natural occurrence known asplasticity. Alice will keep supporters informed of Julius’ progress through a blog with information shared to those who are interested in following along
</div>
<div><br />
</div>
<div><br />
</div>
<div>Costs:
</div>
<div><br />
</div>
<div>NeuroCytronix- Cytotron Treatment for Julius
</div>
<div>Travel:
</div>
<div>$35,000.
</div>
<div>Treatment for 30 days at the NeuroCytronix Centre
</div>
<div>$218.
</div>
<div>International Health Insurance (Required)
</div>
<div>$987.
</div>
<div>Airfare 3 tickets economy round trip, baggage fees &amp; Insurance policy
</div>
<div>$4,259.46
</div>
<div>Lodging: One month 3,565 + 570.40 VAT= 4135.40 + 3% =
</div>
<div>$4,259.46
</div>
<div>31 nights (115. Per night + 16% VAT =3% Tax per night)
</div>
<div>$500.
</div>
<div>Public Transportation: Estimated @ $20/day
</div>
<div>$3,000- 4,500.
</div>
<div>Food: Estimated 100.- 150 /day
</div>
<div>$1,000 Misc
</div>
<div>______________
</div>
<div>$46,465.00
</div>
<div><br />
</div>
<div><br />
</div>
<div>CONTACTS:
</div>
<div>Tania Landois Initial Contact
</div>
<div>Patient Relations Director
</div>
<div>NeuroCytonix Mexico
</div>
<div>Calzada San Pedro 503
</div>
<div>Colonia del Valle CP. 66224
</div>
<div>San Pedro Garza García, N.L.
</div>
<div>TEL MEX: +52 81 3541 4706
</div>
<div>CELL USA: +1 240 506 - 3121
</div>
<div>[email redacted]
</div>
<div><a href="https://www.neurocytonix.com" target="_blank" rel="noreferrer noopener">www.neurocytonix.com</a>
</div>
<div><br />
</div>
<div><br />
</div>
<div><br />
</div>
<div>Daniel Trujillo, M.S. Invoice
</div>
<div>Business Manager, NeuroCytonix, Inc.
</div>
<div>2273 Research Blvd, Suite 725
</div>
<div>Rockville, MD, 20850
</div>
<div>C: +1.240.750.9832
</div>
<div>O: +1.240.243.6455
</div>
<div>F: +1.240.388.9113
</div>
<div><a href="https://www.neurocytonix.com" target="_blank" rel="noreferrer noopener">www.neurocytonix.com</a>
</div>
<div><br />
</div>
<div><br />
</div>
<div>[email redacted]
</div>
<div><br />
</div>
<div>Laurent Lavigne du Cadet
</div>
<div>Chief Financial Officer – Chief Operating Officer
</div>
<div>NeuroCytonix, Inc.
</div>
<div>please visit neurocytonix.com2273 Research Blvd, Suite 725
</div>
<div>Rockville, MD, 20850
</div>
<div>Office [phone redacted]
</div>
<div>Cell +1 202 569 99 95
</div>
<div><br />
</div>
<div>Paulina Botello Health Insurance
</div>
<div>Patients Relations Coordinator
</div>
<div>NeuroCytonix Mexico
</div>
<div>Tel. +52 81 3541 4706
</div>
<div>Cel. + 1 (240) [phone redacted]
</div>
<div>Calzada San Pedro 503
</div>
<div>Colonia del Valle CP. 66224
</div>
<div>San Pedro Garza García, N.L.
</div>
<div>[email redacted]
</div>
<div><a href="https://www.neurocytonix.com" target="_blank" rel="noreferrer noopener">www.neurocytonix.com</a>
</div>
<div><br />
</div>
<div><br />
</div>
<div><br />
</div>
<div>Lic. Mariana Salcido Hotel Accomodations
</div>
<div>Concierge
</div>
<div>NeuroCytonix Mexico
</div>
<div>Calzada San Pedro 503
</div>
<div>Colonia del Valle CP. 66224
</div>
<div>San Pedro Garza García, N.L.
</div>
<div>TEL MEX: +52 81 3551 3171
</div>
<div><a href="https://neurocytonix.com" target="_blank" rel="noreferrer noopener">[email redacted]</a>
</div>

Caryn Louise Leschen

AmyAndy Weyrich

Janine Darby

Tad Creasey

Elizabeth Zehm

Gerrard Durkin

Alexandra Sutliff

Janice Hoffmann

Diane Jones

Lori Mann

Larisa Salmon

Anonymous

Matthew Steubing

Tina Fleck

Claremont UCC

Lydia de los Rios

John Gabel

Jennifer Fog

Help Julius Access Life-Changing Treatment

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

NPO recommendations prod

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Help Julius Access Life-Changing Treatment

Still $38,401 to go. Help us build momentum.